Anti-POPDC2 monoclonal antibody

Pre-made anti-POPDC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to POPDC2/POPDC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1431-Ab-1/ GM-Tg-hg-IP1431-Ab-2Anti-Human POPDC2 monoclonal antibodyHuman
GM-Tg-rg-IP1431-Ab-1/ GM-Tg-rg-IP1431-Ab-2Anti-Rat POPDC2 monoclonal antibodyRat
GM-Tg-mg-IP1431-Ab-1/ GM-Tg-mg-IP1431-Ab-2Anti-Mouse POPDC2 monoclonal antibodyMouse
GM-Tg-cynog-IP1431-Ab-1/ GM-Tg-cynog-IP1431-Ab-2Anti-Cynomolgus/ Rhesus macaque POPDC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1431-Ab-1/ GM-Tg-felg-IP1431-Ab-2Anti-Feline POPDC2 monoclonal antibodyFeline
GM-Tg-cang-IP1431-Ab-1/ GM-Tg-cang-IP1431-Ab-2Anti-Canine POPDC2 monoclonal antibodyCanine
GM-Tg-bovg-IP1431-Ab-1/ GM-Tg-bovg-IP1431-Ab-2Anti-Bovine POPDC2 monoclonal antibodyBovine
GM-Tg-equg-IP1431-Ab-1/ GM-Tg-equg-IP1431-Ab-2Anti-Equine POPDC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1431-Ab-1/ GM-Tg-hg-IP1431-Ab-2; GM-Tg-rg-IP1431-Ab-1/ GM-Tg-rg-IP1431-Ab-2;
GM-Tg-mg-IP1431-Ab-1/ GM-Tg-mg-IP1431-Ab-2; GM-Tg-cynog-IP1431-Ab-1/ GM-Tg-cynog-IP1431-Ab-2;
GM-Tg-felg-IP1431-Ab-1/ GM-Tg-felg-IP1431-Ab-2; GM-Tg-cang-IP1431-Ab-1/ GM-Tg-cang-IP1431-Ab-2;
GM-Tg-bovg-IP1431-Ab-1/ GM-Tg-bovg-IP1431-Ab-2; GM-Tg-equg-IP1431-Ab-1/ GM-Tg-equg-IP1431-Ab-2
Products NameAnti-POPDC2 monoclonal antibody
Formatmab
Target NamePOPDC2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-POPDC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1431-Ag-1Recombinant multi-species POPD2/ POPDC2/ POP2 protein


    Target information

    Target IDGM-IP1431
    Target NamePOPDC2
    Gene ID64091,64082,360718,712853,487996,101080567,540535,100070977
    Gene Symbol and SynonymsPOP2,POPDC2
    Uniprot AccessionQ9HBU9
    Uniprot Entry NamePOPD2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000121577
    Target ClassificationN/A

    The target: POPDC2, gene name: POPDC2, also named as POP2. This gene encodes a member of the POP family of proteins which contain three putative transmembrane domains. This membrane associated protein is predominantly expressed in skeletal and cardiac muscle, and may have an important function in these tissues. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.